AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Karachi: BF BioSciences Limited, located at Rawalpindi, has scheduled a significant board meeting for October 27, 2024, via video link. This meeting will focus on the quarterly accounts for the period ending September 30, 2024, specifically to discuss the declaration of any entitlements. According to information available from the Pakistan Stock Exchange (PSX), this meeting is crucial for financial disclosures and compliance.
The company has also announced a closed period from October 21 to October 27, 2024, as mandated by PSX Regulation 5.6.1(d). During this period, directors, the CEO, and other executives are prohibited from trading shares of the company, ensuring no insider trading occurs based on the upcoming quarterly financial disclosures.
BF BioSciences has urged the TRE Certificate Holders of the exchange to be informed of these developments to maintain transparency and regulatory compliance. The company’s commitment to stringent compliance and ethical management of its financial practices reflects its dedication to shareholder interests and market regulations.
The post BF BioSciences Limited Announces Board Meeting to Discuss Quarterly Results appeared first on .